Russians significantly increase foreign drug purchases

2 May 2023
russia_pharmacy_big

Russians have significantly increased drugs purchases from other countries amid the ever-declining domestic range and the ever-growing isolation of the country in the international arena, reports The Pharma Letter’s local correspondent.

As the range of drugs available in Russian pharmacies has substantially declined after the February 2022 invasion of Ukraine, many of Russian citizens, travelling abroad in recent months have increased purchases of foreign drugs including those in reserve for further use as there is a high possibility that the current situation with drugs in Russia will continue to deteriorate. The range of such drugs is wide from painkillers to antibiotics.

Most of analysts expect foreign drugs purchases by will continue to grow despite those measures that are being taken by local authorities for the restriction of such supplies.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical